Device Cost-Effectiveness Studies Need Better Standards - Rep. Eshoo
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration's increasing demand for device cost benefit data requires industry to develop a "new yardstick" to better define standards for cost effectiveness studies, Rep. Anna Eshoo (D-Calif.) said March 15.